-
Egypt and Syria Sign Agreement to Restore Direct Flights After 14-Year Hiatus
-
Professor Shahida Moosa Pioneers Medical Genomics in South Africa Amid Testing Shortages
-
Van Gogh’s ‘Châtaigniers en Fleurs’ Sets $285m Record at Sotheby’s
-
Texas Marijuana Decriminalization Faces Uncertain Future Under New Attorney General
-
Anthropic Sets Record $81.3 Billion IPO Valuing AI Firm at $1.5 Trillion
-
Early Black Friday Laptop Deals: MacBook Neo, IdeaPad Slim 5x, and Surface Laptop Prices Drop
-
eThekwini Faces R6.5bn Flood Claim from Toyota’s Insurer
-
2026 East Bay Nosh Awards Voting Opens for Food and Drink Favorites
-
Guanajuato Silver Reports Q3 Operating and Financial Results
-
Skilled Nursing Facilities Face 2027 Revenue Cycle Reckoning as Payer Burdens Reshape Admissions and Outsourcing
-
Golden Minerals Completes Drilling Desierto, Argentina
-
Gamma Resources Announces Expansion of Mesa Arc Uranium Project in New Mexico to 4,760 Acres, Completes Radon Flux Baseline Survey
-
Trustpoint Xposure Completes More Than 200 AI Visibility Audits Across Professional Services
-
NoHo, Inc. Acquires Four Placer Gold Claims in Clark County, Nevada from Gold Stake Mining Inc.
-
IRS Shuts Down FIRE Today: What Information Return Filers Need to Know Before the 2027 Filing Season
-
First Canadian Graphite Reports 43.9% Graphitic Carbon Sample and Encouraging Coarse-Flake Characteristics at Zone 13 at Lac Guéret South
-
LASE to Premiere Quantum Bullet(TM) at Counter UAS Technology Conference in Washington, D.C.
-
American Critical Minerals Reports High Grade Potash Intersection of 6.55m Grading 38.51 wt.% KCl at its Green River Project, Utah
-
Hemogenyx Pharmaceuticals PLC - Chairman Receives Prestigious Award
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 19
-
Bob's Watches Founder Paul Altieri Unveils Private Collection of Vintage Rolex Watches in New Book, "NOT FOR SALE"
-
Making the Most of a Long Weekend Without Leaving Town
-
Helio Corporation Engages CORE IR to Provide Investor Relations, Capital Markets Advisory and Media Relations Services
-
Greene Concepts Connects Consumer Needs with Manufacturing Strategy
-
Karbon-X (OTCQB:KARX) Enters California's Multi-Billion-Dollar Compliance Carbon Market Following CITSS Approval
-
Valion Bio Welcomes Former U.S. Army Regulatory Leader and Biotech CEO Dr. Armand Balboni as Advisor in Run-up to Entolimod Therapeutic Efficacy Data Readout
-
multiQure Begins Manufacturing Phase of MQ-201 Gene Therapy for First Huntington's Disease Patients - U.S.-Based Andelyn Biosciences Selected as Manufacturing Partner
-
Arrive AI Eliminates All Debt Through Preferred Equity Exchange
-
QNX Brings Physical AI and Next-Generation Software-Defined Vehicle Innovation to CES 2027
-
More Than Half of Teen AI Chatbot Users Use Them Daily, and 46% Say It Feels Like Talking to a Human, New Family Online Safety Institute Research Finds
-
MicroVision and Blue-Band to Support $3 Million Federally Funded Intelligent Transportation Initiative in Louisville, Kentucky
-
The 2026 MDaudit Annual Benchmark Report Spotlights AI's Impact on Financial Risk as Payer Denials and Audits Continue an Upward Trajectory
-
Metano Emerges From Stealth to Unify AI Agent Security Across the Enterprise
-
Lumber's Union CBA Agent Launches in Sage Agent Marketplace to Help Simplify Union Payroll Compliance
-
ATWEC Technologies, Inc. (OTCID: ATWT) Engages Michael Gillespie & Associates, PLLC to Audit Fiscal 2026 and 2025 Consolidated Financial Statements and Changes Fiscal Year End to October 31
-
Anti-Bullying Week: Five Warning Signs Parents Should Monitor
Stemtech Corporation Partners with Fitness Icon Tony Little to Launch Stemtech Biosciences Digital Campaign
"America's Personal Trainer" teams with the pioneer in stem cell nutrition to bring plant-based Stemceuticals™ to a new generation of U.S. consumers
NAPLES, FL / ACCESS Newswire / November 19, 2026 / Stemtech Corporation (OTCID:STEK) - Stemtech Corporation, the global pioneer in stem cell nutrition, today announced a marketing and representation agreement with fitness icon Tony Little and his company, Mindset Productions, LLC. Tony Little will serve as the face of a new U.S. digital and social media campaign for Stemtech BioSciences, the Company's direct-to-consumer e-commerce channel at www.stemtechbiosciences.com.

The initial 90-day campaign phase will run on Tony Little's social media channels, with Meta and Instagram as lead platforms. It will feature new Tony Little videos each week, supported by educational graphics and infographics. Filming begins in November, and the first posts are expected to go live the second week of November 2026.
The campaign will feature four of Stemtech's leading Stemceuticals™: the RCM Pack, StemRelease3™, StemFlo® Advanced and MigraStem®. Consumers will be able to buy these products at special Tony Little pricing, using the Tony Little promotional code at the Stemtech BioSciences online store. The program is available in the United States only.
The campaign will present Stemtech's plant-based nutrition as one part of a broader healthy lifestyle that includes regular exercise, quality rest and a balanced diet. These are themes Tony Little has championed for more than four decades.
A New Channel for a Proven Product Line
Charles S. Arnold, Chairman and CEO of Stemtech Corporation, said: "Tony Little has inspired millions of Americans to take charge of their health, and his energy and credibility are a natural fit for Stemtech. For more than 20 years, our Stemceuticals™ have supported the body's own natural renewal process. With Tony, we are introducing that science to consumers who have never heard of stem cell nutrition. This campaign lets us test a powerful new sales channel while we keep investing in the products and the people who built this company."
John W. Meyer, President & COO of Stemtech, said: "We launched Stemtech BioSciences to bring our products to a wider retail audience, and influencer partnerships were always part of that plan. Tony is the ideal partner to lead it. His message of exercise, rest, good nutrition and a positive mindset matches exactly how we want people to think about wellness. We will track results closely during the first 90 days, and those results will guide how we grow the program."
Tony Little said: "I've spent my whole career helping people feel better and live better, and I only put my name behind things I believe in. Feeling good starts on the inside. Stemtech's natural, plant-based approach to nutrition fits right in with how I train and how I live. I can't wait to share it with my audience."
ABOUT TONY LITTLE
Tony Little, widely known as "America's Personal Trainer," is a fitness personality, entrepreneur and motivational speaker. He has spent more than 40 years helping people pursue healthier, more active lives.
ABOUT STEMTECH CORPORATION
Stemtech Corporation (OTCID:STEK) is a publicly traded wellness company and the global pioneer in stem cell nutrition. Founded in California in 2005 and headquartered in Naples, Florida since 2014, Stemtech created Stemceuticals™: all-natural, plant-based products that support the body's natural regenerative process. Stemtech markets its products through Independent Business Partners in markets around the world and through Stemtech BioSciences, its U.S. direct-to-consumer e-commerce channel. For more information, visit www.stemtech.com and www.stemtechbiosciences.com.
FORWARD LOOKING STATEMENTS
This announcement contains forward-looking statements within the meaning of the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, those identified by words such as "believes," "will," "expects," "anticipates," "estimates," "intends," "plans," "targets," "projects" and similar expressions. The statements in this release are based upon the current beliefs and expectations of our company's management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in these forward-looking statements. Numerous factors could cause or contribute to such differences, including, but not limited to, the results of clinical trials and/or other studies, the challenges inherent in new product development initiatives, the impact of any competitive products, our ability to license and protect our intellectual property, our ability to raise additional capital in the future, changes in government policy and/or regulation, potential litigation by or against us, any governmental review of our products or practices, and other risks discussed from time to time in our filings with the Securities and Exchange Commission. We undertake no obligation to update any forward-looking statements, or any information contained in this press release or in other public disclosures, at any time. Finally, the investing public is reminded that only announcements or information about Stemtech Corporation disseminated by the Company and bearing its name are considered official.
For Investor Relations Information Contact:
CEO Charles S. Arnold
Email: [email protected]
Phone: +1 336-918-0507
Stemtech Corporation
Phone: +1 954-715-6000 ext 1040
Email: [email protected]
SOURCE: Stemtech Corporation
View the original press release on ACCESS Newswire
J.Williams--AMWN